Literature DB >> 36157626

Embedded Palliative Care for Amyotrophic Lateral Sclerosis: A Pilot Program and Lessons Learned.

Kelly Fahrner-Scott1, Carly Zapata1, David L O'Riordan1, Eve Cohen1, Laura Rosow1, Steven Z Pantilat1, Catherine Lomen-Hoerth1, Kara E Bischoff1.   

Abstract

Background and
Objectives: Palliative care (PC) is recommended for people with amyotrophic lateral sclerosis (ALS), but there is scant literature about how to best provide this care. We describe the structure and impact of a pilot program that integrates longitudinal, interdisciplinary PC into the care of patients with ALS.
Methods: Observational cohort study of patients with ALS referred to outpatient PC and seen for at least 3 PC visits October 2017-July 2020.
Results: Fifty-five patients met the inclusion criteria. Three-quarters (74.5%) were Caucasian, and 78.2% spoke English. Patients were referred for advance care planning (58.2%), support for patient/family (52.7%), and symptoms other than pain (50.9%). Patients had a mean of 5 scheduled PC visits, the majority occurred by video. A PC physician, nurse, social worker, and chaplain addressed pain (for 43.6% of patients), nonpain symptoms (94.5%), psychosocial distress (78.2%), spiritual concerns (29.1%), care planning (96.4%), and supported family caregivers (96.4%). With PC, the rate of completion of advance directives increased from 16.4% to 36.4% (p = 0.001) and Physician Orders for Life-Sustaining Treatment forms from 10.9% to 63.6% (p < 0.001). Of the 27 patients who died, 77.8% used hospice, typically for more than 30 days. Eleven patients obtained aid-in-dying prescriptions, and 8 took these medications, accounting for 29.6% of the deaths. Discussion: Integrating longitudinal, interdisciplinary PC into the care of patients with ALS is feasible, addresses needs in multiple domains, and is associated with increased rates of advance care planning. Controlled studies are needed to further elucidate the impact of PC on patients with ALS, their families, and clinicians.
© 2021 American Academy of Neurology.

Entities:  

Year:  2022        PMID: 36157626      PMCID: PMC9491500          DOI: 10.1212/CPJ.0000000000001124

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  30 in total

1.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.

Authors:  P M Andersen; G D Borasio; R Dengler; O Hardiman; K Kollewe; P N Leigh; P-F Pradat; V Silani; B Tomik
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

Review 2.  Neurologists as primary palliative care providers: Communication and practice approaches.

Authors:  Claire J Creutzfeldt; Maisha T Robinson; Robert G Holloway
Journal:  Neurol Clin Pract       Date:  2016-02

3.  End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease.

Authors:  Hon Wai Benjamin Cheng; Oi Man Iman Chan; Chun Hung Red Chan; Wan Hung Chan; Koon Sim Fung; Kar Yin Wong
Journal:  Am J Hosp Palliat Care       Date:  2017-10-15       Impact factor: 2.500

Review 4.  Amyotrophic lateral sclerosis.

Authors:  J D Mitchell; G D Borasio
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

5.  The final month of life in patients with ALS.

Authors:  Linda Ganzini; Wendy S Johnston; Maria J Silveira
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

6.  Dying of amyotrophic lateral sclerosis: Health care use and cost in the last year of life.

Authors:  Jocelyn Zwicker; Danial Qureshi; Robert Talarico; Pierre Bourque; Mary Scott; Nicolas Chin-Yee; Peter Tanuseputro
Journal:  Neurology       Date:  2019-10-31       Impact factor: 9.910

7.  Stakeholder Perspectives on the Biopsychosocial and Spiritual Realities of Living With ALS: Implications for Palliative Care Teams.

Authors:  Klaudia Kukulka; Karla T Washington; Raghav Govindarajan; David R Mehr
Journal:  Am J Hosp Palliat Care       Date:  2019-03-03       Impact factor: 2.500

Review 8.  ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?

Authors:  Dmitry Petrov; Colin Mansfield; Alain Moussy; Olivier Hermine
Journal:  Front Aging Neurosci       Date:  2017-03-22       Impact factor: 5.750

Review 9.  Palliative care in motor neurone disease: where are we now?

Authors:  David J Oliver
Journal:  Palliat Care       Date:  2019-01-21

10.  Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.

Authors:  Brook Calton; William Patrick Shibley; Eve Cohen; Steven Z Pantilat; Michael W Rabow; David L O'Riordan; Kara E Bischoff
Journal:  Palliat Med Rep       Date:  2020-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.